These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 2694631)
1. [Disorders of lipid metabolism in diabetes mellitus]. Biesenbach G Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631 [TBL] [Abstract][Full Text] [Related]
2. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment]. Keller U; Golay A; Pometta D Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1199-204. PubMed ID: 2237046 [TBL] [Abstract][Full Text] [Related]
3. [Diabetes mellitus and lipoproteins]. Somogyi A Orv Hetil; 1993 Oct; 134(43):2371-7. PubMed ID: 8233456 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [TBL] [Abstract][Full Text] [Related]
5. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes. Temelkova-Kurktschiev T; Hanefeld M Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770 [TBL] [Abstract][Full Text] [Related]
6. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]
7. Abnormal particle size of lipoprotein in non-insulin-dependent diabetics and nondiabetics with and without hyperlipidemia. Nakajo Y; Tanaka A; Uchimura I Bull Tokyo Med Dent Univ; 1991 Dec; 38(4):63-71. PubMed ID: 1764762 [TBL] [Abstract][Full Text] [Related]
8. Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis. Schwandt P Horm Metab Res Suppl; 1985; 15():80-3. PubMed ID: 3865885 [TBL] [Abstract][Full Text] [Related]
9. [HDL-cholesterol in diabetes mellitus. Analysis of type of diabetes, therapy, duration of disease and metabolic control (author's transl)]. Prager R; Schernthaner G; Müller MM Wien Klin Wochenschr; 1980 Oct; 92(19):672-7. PubMed ID: 7008366 [TBL] [Abstract][Full Text] [Related]
10. Dyslipoproteinaemia in manifest diabetes. Manzato E; Crepaldi G J Intern Med Suppl; 1994; 736():27-31. PubMed ID: 7986305 [TBL] [Abstract][Full Text] [Related]
11. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics]. Mudríková T; Tkác I; Takác M Vnitr Lek; 1994 Apr; 40(4):250-4. PubMed ID: 8184588 [TBL] [Abstract][Full Text] [Related]
12. [Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism]. Krone W; Müller-Wieland D; Wirth H Fortschr Med; 1992 Dec; 110(34):645-8. PubMed ID: 1483617 [TBL] [Abstract][Full Text] [Related]
13. [Dyslipoproteinemia and diabetes mellitus]. Vaverková H Vnitr Lek; 2000 Sep; 46(9):532-8. PubMed ID: 11344647 [TBL] [Abstract][Full Text] [Related]
15. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Vergès BL Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991 [TBL] [Abstract][Full Text] [Related]
16. Management of hyperlipidemia in diabetes mellitus. Dunn FL Endocrinol Metab Clin North Am; 1992 Jun; 21(2):395-414. PubMed ID: 1612072 [TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular disease. Vogelberg KH; Grimm K; Gries FA Horm Metab Res Suppl; 1985; 15():90-4. PubMed ID: 3865888 [TBL] [Abstract][Full Text] [Related]
18. [Effect of chronic alcohol consumption on blood lipid levels and angiopathy in diabetics]. Bertello PD; Gurioli LZ; Gurioli LR; Magro E Minerva Med; 1989 May; 80(5):443-6. PubMed ID: 2747971 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients. González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671 [TBL] [Abstract][Full Text] [Related]
20. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients. Yoshida H; Hirowatari Y; Kurosawa H; Tada N Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]